Connect Biopharma Holdings Ltd
NASDAQ:CNTB
Cash Flow Statement
Cash Flow Statement
Connect Biopharma Holdings Ltd
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(16)
|
(26)
|
(47)
|
(64)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
7
|
3
|
2
|
3
|
|
| Other Non-Cash Items |
7
|
8
|
7
|
7
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(15)
|
(16)
|
1
|
0
|
|
| Cash from Operating Activities |
(24)
N/A
|
(34)
-42%
|
(38)
-14%
|
(56)
-46%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
(3)
|
(23)
|
(31)
|
(16)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(24)
-598%
|
(31)
-30%
|
(17)
+46%
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
0
+1%
|
0
+90%
|
1
+49%
|
|
| Change in Cash | |||||
| Effect of Foreign Exchange Rates |
(1)
|
(1)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(27)
N/A
|
(58)
-111%
|
(69)
-19%
|
(72)
-4%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
(24)
N/A
|
(34)
-41%
|
(39)
-13%
|
(56)
-45%
|
|